Ljlacto 6 capsule Vaginali 100.000.000ufc

NAME
SOFTIGYN 100,000,000 UFC SOFT VAGINAL CAPSULES

PHARMACOTHERAPEUTIC CATEGORY
Antimicrobials and antiseptics.

ACTIVE PRINCIPLES
Lactobacillus plantarum P 17630 at least 10 ^ 8.

EXCIPIENTS
Sodium ethyl p-oxybenzoate; sodium propyl p-oxybenzoate; medium chain triglycerides; silica (Aerosil 300); jelly; glycerol; dimethylpolysiloxane; titanium dioxide (E 171).

INDICATIONS
Treatment of vaginitis and vulvo-vaginitis in general, as the lactobacilli present in them, implanting and multiplying on the vaginal mucosa, in addition to restoring the autochthonous bacterial flora to equilibrium, indirectly antagonize the colonization of pathogenic germs by competition; topical therapy, starting from the fertile age, of vaginal infections sustained by pathogenic germs; vaginitis associated with ovarian failure, hypofollicolinic leukorrhea, vaginitiseniles, vulvar pruritus, vaginal dystrophy; adjuvant in the chemotherapy and antibiotic treatment in Trichomonas vaginitis.

CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance or to any of the excipients.

DOSAGE
One vaginal capsule per day. Introduce a capsule deeply into the vagina, in the supine position, in the evening before bedtime.

STORAGE
Store the medicine at a temperature between +2 and +8 degreesC.

WARNINGS
The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena and produce unwanted effects. In this case it is necessary to stop the treatment and consult your doctor. The drug does not replace antibiotic or chemotherapy therapy, but represents a useful complement by restoring, especially at the end of the specific treatment, the physiological conditions of the vaginal environment.

INTERACTIONS
No interaction studies have been performed.

SIDE EFFECTS
No undesirable effects related to the use of the medicine have been reported. The reporting of suspected adverse reactions that occur after the authorization of the drug is important, as it allows continuous monitoring of the benefit / risk ratio of the drug. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system.

PREGNANCY AND BREASTFEEDING
Lactobacillus plantarum is a non-pathogenic habitual host of the vagina, therefore the medicine can be used during pregnancy and / or breastfeeding.